Impact of Subcutaneous Electric Lumbar Stimulation on Treatment of Refractory Chronic and Disabling Lumbago
CompletedNot applicableNCT02988830
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of the study is to show that subcutaneous electric lumbar stimulation reduces pain in chronic lumbago after 12 months of treatment.
Study details
- Official title
- Impact of Subcutaneous Electric Lumbar Stimulation on Treatment of Refractory Chronic and Disabling Lumbago
- Conditions
- Interventions
- Device: Subcutaneous Electric Lumbar Stimulation
- Sponsor
- Hopital Foch
- Start date
- 2016-11-29
- Primary completion
- 2022-01-27
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- France
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * patients over 18 years old * Having given their non-opposition * Affiliated to a national insurance scheme or beneficiary * Suffering for more than a year from a chronic, invalidating lumbago that is refractory in several lines of treatments Exclusion Criteria: * patients with lumbago that can be surgically handled or which justified a medullary stimulation * having been operated for the rachis for less than 6 months; * which cannot for cognitive or cultural reasons contribute to the planned evaluations and to the management of the material (remote control); * for who the investigator can plan that they cannot be followed during one year from the date of the setting-up (non-observance, planned moving, etc.); * which present psychological, local or general contraindications to the setting-up of a neurostimulation device (Impossibility to stop anticoagulants or aggregation inhibitors, disturb of the hemostasis, cutaneous infection change on the site of setting-up) * MRI planned within the next year * pregnant or breast-feeding women.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02988830